REGENXBIO (RGNX) Debt/EBITDA US GAAP (year values) |
||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| Debt/EBITDA | 1.05 | 1.10 | 0.78 | 0.77 | -0.21 | 0.34 | ||
| Changes by years, y/y, % | -148% | +5% | -30% | -1% | -127% | |||
REGENXBIO. Debt/EBITDA
REGENXBIO. Debt/EBITDA, changes, %
REGENXBIO (RGNX) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Debt/EBITDA | 1.54 | 1.89 | 0.05 | -0.23 | 0.34 | 0.34 | ||
| Changes by years, y/y, % | +116% | +214% | -94% | -130% | -78% | |||
| Changes by quarters, q/q, % | +99% | +23% | -97% | -552% | -248% | |||